Dual contrast liver MRI: a pictorial illustration
- PMID: 34076723
- DOI: 10.1007/s00261-021-03129-1
Dual contrast liver MRI: a pictorial illustration
Abstract
Liver magnetic resonance imaging (MRI) is a commonly performed imaging technique with multiple indications and applications. There are two general groups of contrast agents used when imaging the liver, extracellular contrast agents (ECA) and hepatobiliary agents (HBA), each of which has its own advantages and limitations. Liver MRI with ECA provides excellent information on abdominal vasculature and better quality multi-phasic studies for characterization of focal liver lesions. HBA improves lesion detection, provides information regarding liver function and can be helpful for evaluating biliary tree anatomy, excretion, anastomotic stenoses, or leaks. Most liver MRI studies are usually performed with one agent, however in some cases, a second study is performed with another agent to obtain additional information or confirm the findings in the first study. Administering both agents in a single exam can potentially eliminate the need for additional imaging in certain situations. In this pictorial review, the techniques and indications for dual contrast MRI will be detailed with multiple demonstrative examples.
Keywords: Extracellular contrast agent; Focal nodular hyperplasia; Hepatic adenoma; Hepatobiliary contrast agent; Liver metastases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma.Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2515-25. Eur Rev Med Pharmacol Sci. 2016. PMID: 27383300
-
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs.J Hepatol. 2020 May;72(5):937-945. doi: 10.1016/j.jhep.2019.12.011. Epub 2019 Dec 21. J Hepatol. 2020. PMID: 31870951 Clinical Trial.
-
Diagnostic performance of MRI for HCC according to contrast agent type: a systematic review and meta-analysis.Hepatol Int. 2020 Dec;14(6):1009-1022. doi: 10.1007/s12072-020-10100-7. Epub 2020 Nov 4. Hepatol Int. 2020. PMID: 33146841
-
Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI.Abdom Radiol (NY). 2019 Jul;44(7):2366-2376. doi: 10.1007/s00261-019-01968-7. Abdom Radiol (NY). 2019. PMID: 30847566
-
Update on MR Contrast Agents for Liver Imaging: What to Use and When.Radiol Clin North Am. 2022 Sep;60(5):679-694. doi: 10.1016/j.rcl.2022.04.005. Epub 2022 Jul 15. Radiol Clin North Am. 2022. PMID: 35989037 Review.
References
-
- Davenport, M.S., et al., Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology, 2013. 266(2): p. 452-61. - DOI
-
- Motosugi, U., et al., An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Radiology, 2016. 279(1): p. 93-102. - DOI
-
- Pietryga, J.A., et al., Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Radiology, 2014. 271(2): p. 426-34. - DOI
-
- Chen, L., et al., Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One, 2012. 7(11): p. e48681.
-
- Grazioli, L., et al., Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology, 2012. 262(2): p. 520-9. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous